"Change over time in the treatment of pemphigus vulgaris between 2004 and 2016 in Iran" : A multiple cross-sectional study
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Dermatologic therapy - 32(2019), 2 vom: 12. März, Seite e12827 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Salarvand, Fereshteh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4F4X42SYQ6 |
|---|
| Anmerkungen: |
Date Completed 13.11.2019 Date Revised 13.11.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/dth.12827 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM292874529 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM292874529 | ||
| 003 | DE-627 | ||
| 005 | 20231225074100.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/dth.12827 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0976.xml |
| 035 | |a (DE-627)NLM292874529 | ||
| 035 | |a (NLM)30659718 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Salarvand, Fereshteh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a "Change over time in the treatment of pemphigus vulgaris between 2004 and 2016 in Iran" |b A multiple cross-sectional study |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.11.2019 | ||
| 500 | |a Date Revised 13.11.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Dermatologic Agents |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 650 | 7 | |a Rituximab |2 NLM | |
| 650 | 7 | |a 4F4X42SYQ6 |2 NLM | |
| 700 | 1 | |a Fatehi, Zahra |e verfasserin |4 aut | |
| 700 | 1 | |a Shahali, Maryam |e verfasserin |4 aut | |
| 700 | 1 | |a Balighi, Kamran |e verfasserin |4 aut | |
| 700 | 1 | |a Ghiasi, Maryam |e verfasserin |4 aut | |
| 700 | 1 | |a Abedini, Robabeh |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmoudi, Hamidreza |e verfasserin |4 aut | |
| 700 | 1 | |a Tavakolpour, Soheil |e verfasserin |4 aut | |
| 700 | 1 | |a Chams-Davatchi, Cheyda |e verfasserin |4 aut | |
| 700 | 1 | |a Daneshpazhooh, Maryam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Dermatologic therapy |d 1998 |g 32(2019), 2 vom: 12. März, Seite e12827 |w (DE-627)NLM096394870 |x 1529-8019 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2019 |g number:2 |g day:12 |g month:03 |g pages:e12827 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/dth.12827 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2019 |e 2 |b 12 |c 03 |h e12827 | ||